Andrés José Maria Ferreri
Clinical trials sponsored by Andrés José Maria Ferreri, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Real-world data on epcoritamab for tough-to-treat lymphoma Results expected Dec 2026 (estimated)
- New hope for lymphoma patients: mosunetuzumab under review Results expected Dec 2026 (estimated)